Lockheed Martin (NYSE: LMT) has been awarded $170 million in new Health & Human Services (HHS) information technology contracts, all geared toward improving efficiency in our nation's health systems.
The new contracts include $142 million for task orders under the HHS Program Support Center ID/IQ contract, and $28 million for the National Institutes of Health's Office of Computer and Communications Systems (OCSS) Software Support Services.
"The transformation of our health care system is a priority for this nation," said Steve Lubniewski, vice president, Lockheed Martin Health Solutions. "For Lockheed Martin, it's a challenge of human security: How are we advancing technology to support our customers in their mission to deliver accessible, quality healthcare? It starts with work like this -- ensuring the efficient and secure operation of the health systems that serve America's citizens."
Under the HHS Program Support Center task orders, Lockheed Martin will provide HHS with desktop support services, help desk and call center services, systems administration and email support, and general operations and maintenance. The consolidated task order has a three-year base period and four one-year options.
For the NIH, Lockheed Martin will provide support in web and application design and development, database design, infrastructure analysis and planning, network and system operations, and information assurance and system and network security. The contract has a five-year base period with four one-year options.
Lockheed Martin has been providing IT services to the healthcare community for nearly two decades, serving customers such as the Centers for Disease Control, Centers for Medicaid & Medicare Services, Federal Occupational and Health, the Social Security Administration, and the Department of Defense and Department of Veteran Affairs. The company's Health team includes more than 2,500 highly skilled clinical, scientific and technical professionals with expertise in health IT, research, bioinformatics and medical services.
The future of UK life sciences starts in the West Midlands